78 related articles for article (PubMed ID: 28150408)
1. Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer.
Utsumi F; Kajiyama H; Niimi K; Sekiya R; Sakata J; Suzuki S; Shibata K; Mizuno M; Kikkawa F
J Obstet Gynaecol Res; 2017 Feb; 43(2):365-370. PubMed ID: 28150408
[TBL] [Abstract][Full Text] [Related]
2. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
[TBL] [Abstract][Full Text] [Related]
3. Benefit of palliative chemotherapy and hospice enrollment in late-stage ovarian cancer patients.
Tsubamoto H; Ito Y; Kanazawa R; Wada R; Hosoda Y; Honda O; Takeyama R; Sakane R; Wakimoto Y; Shibahara H
J Obstet Gynaecol Res; 2014 May; 40(5):1399-406. PubMed ID: 24605763
[TBL] [Abstract][Full Text] [Related]
4. Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.
Lopez-Acevedo M; Havrilesky LJ; Broadwater G; Kamal AH; Abernethy AP; Berchuck A; Alvarez Secord A; Tulsky JA; Valea F; Lee PS
Gynecol Oncol; 2013 Jul; 130(1):156-61. PubMed ID: 23587882
[TBL] [Abstract][Full Text] [Related]
5. The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life.
Palaia I; Tomao F; Santangelo G; Di Pinto A; Sassu CM; Perniola G; Musella A; Di Donato V; Giancotti A; Benedetti Panici P
Oncology; 2019; 97(5):306-310. PubMed ID: 31437848
[TBL] [Abstract][Full Text] [Related]
6. Survival after Anticancer Treatment of Terminally Ill Patients with Ovarian Carcinoma.
Kajiyama H; Suzuki S; Shimbo A; Utsumi F; Yoshikawa N; Kikkawa F
J Palliat Med; 2020 Aug; 23(8):1060-1065. PubMed ID: 32293976
[No Abstract] [Full Text] [Related]
7. Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer.
Nitecki R; Bercow AS; Gockley AA; Lee H; Penson RT; Growdon WB
Int J Gynecol Cancer; 2020 Feb; 30(2):201-206. PubMed ID: 31911533
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
9. The impact of palliative care on cancer deaths in Hong Kong: a retrospective study of 494 cancer deaths.
Tse DM; Chan KS; Lam WM; Leu K; Lam PT
Palliat Med; 2007 Jul; 21(5):425-33. PubMed ID: 17901102
[TBL] [Abstract][Full Text] [Related]
10. The utilization of palliative care in gynecologic oncology patients near the end of life.
Fauci J; Schneider K; Walters C; Boone J; Whitworth J; Killian E; Straughn JM
Gynecol Oncol; 2012 Oct; 127(1):175-9. PubMed ID: 22735789
[TBL] [Abstract][Full Text] [Related]
11. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S; Scambia G; Katsaros D; Gallo C; Pujade-Lauraine E; De Placido S; Bologna A; Weber B; Raspagliesi F; Panici PB; Cormio G; Sorio R; Cavazzini MG; Ferrandina G; Breda E; Murgia V; Sacco C; Cinieri S; Salutari V; Ricci C; Pisano C; Greggi S; Lauria R; Lorusso D; Marchetti C; Selvaggi L; Signoriello S; Piccirillo MC; Di Maio M; Perrone F; ; ; ; ;
Lancet Oncol; 2014 Apr; 15(4):396-405. PubMed ID: 24582486
[TBL] [Abstract][Full Text] [Related]
12. Family Perspectives on Aggressive Cancer Care Near the End of Life.
Wright AA; Keating NL; Ayanian JZ; Chrischilles EA; Kahn KL; Ritchie CS; Weeks JC; Earle CC; Landrum MB
JAMA; 2016 Jan; 315(3):284-92. PubMed ID: 26784776
[TBL] [Abstract][Full Text] [Related]
13. [Value of serum CA(125) detection for predicting recurrence and prognosis in ovarian epithelial cancer].
Wang XY; Ye J; Feng SW; Lü WG; Wan XY; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):813-6. PubMed ID: 21211277
[TBL] [Abstract][Full Text] [Related]
14. Clinical indicators useful in decision-making about palliative chemotherapy for end-of-life ovarian cancer patients.
Kiuchi K; Hasegawa K; Watanabe M; Motegi E; Kosaka N; Fukasawa I
Arch Gynecol Obstet; 2022 Feb; 305(2):425-430. PubMed ID: 34347151
[TBL] [Abstract][Full Text] [Related]
15. Prolonged disease-free survival by maintenance chemotherapy among patients with recurrent platinum-sensitive ovarian cancer.
Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Blumenson LE
Gynecol Oncol; 1998 Nov; 71(2):190-5. PubMed ID: 9826459
[TBL] [Abstract][Full Text] [Related]
16. [Study of symptoms in terminally ill patients with ovarian carcinoma].
Sun XG; Wu M; Ma SQ; Li CY; Jin LN; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):192-5. PubMed ID: 17537307
[TBL] [Abstract][Full Text] [Related]
17. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.
Oza AM; Cibula D; Benzaquen AO; Poole C; Mathijssen RH; Sonke GS; Colombo N; Špaček J; Vuylsteke P; Hirte H; Mahner S; Plante M; Schmalfeldt B; Mackay H; Rowbottom J; Lowe ES; Dougherty B; Barrett JC; Friedlander M
Lancet Oncol; 2015 Jan; 16(1):87-97. PubMed ID: 25481791
[TBL] [Abstract][Full Text] [Related]
18. Is there any association between where patients spend the end of life and survival after anticancer treatment for gynecologic malignancy?
Kajiyama H; Utsumi F; Higashi M; Sakata J; Sekiya R; Mizuno M; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Niimi K; Shibata K; Kikkawa F
J Palliat Med; 2014 Mar; 17(3):325-30. PubMed ID: 24617316
[TBL] [Abstract][Full Text] [Related]
19. Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service.
Poulose JV; Do YK; Neo PS
J Pain Symptom Manage; 2013 Aug; 46(2):173-81. PubMed ID: 23177723
[TBL] [Abstract][Full Text] [Related]
20. Resource implications of palliative chemotherapy for ovarian cancer.
Doyle C; Stockler M; Pintilie M; Panesar P; Warde P; Sturgeon J; Oza AM
J Clin Oncol; 1997 Mar; 15(3):1000-7. PubMed ID: 9060539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
